Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Acromegaly × Octreotide × Clear all

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neuroendocrine Tumors 5 Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Esophageal Neoplasms 4 Weight Loss 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Malnutrition 2 Intestinal Obstruction 2 Duodenal Neoplasms 2 Diarrhea 2 Colorectal Neoplasms 2 Carcinoid Tumor 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vomiting 1 Vipoma 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Somatostatinoma 1 Serotonin Syndrome 1 Sarcoma 1 Rectal Neoplasms 1 Primary Inoperable Thymoma 1

Interventions

lanreotide 3 Transcranial Magnetic Stimulation 1 Surgical Procedures, Operative 1 Solutions 1 Radiosurgery 1 Octreotide 1 Magnetic Resonance Spectroscopy 1 Injections 1 Dosage Forms 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00616408 2008-02-15

Prediction of Tumor Shrinkage in Acromegaly

Federico II University

Acromegaly

Data powered by HemOnc (CC BY 4.0) Colophon ⚡